Catalyst
Slingshot members are tracking this event:
Phase 2 Top-Line Data for SAGE-217 in Postpartum Depression due H2 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SAGE |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 17, 2018
Occurred Source:
http://investor.sagerx.com/news-releases/news-release-details/sage-therapeutics-present-brexanolone-postpartum-depression-data
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, Top-line, Postpartum Depression, Sage-217
